Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Multiple diseases: should we treat them all?].

J Biollaz1, T Buclin

  • 1Division de pharmacologie et Toxicologie Cliniques CHUV, 1011 Lausanne. jerome.biollaz@chuv.hospvd.ch

Revue Medicale Suisse
|May 19, 2005
PubMed
Summary

Managing multiple diseases requires a patient-centered approach. Prioritize rational prescribing principles for safe and effective polypharmacy, focusing on individual patient needs and clear therapeutic goals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: Influence of hypobaric hypoxia on leptin levels in men.

International journal of obesity (2005)·2024
Same author

Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I study.

Scientific reports·2024
Same author

Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: An update.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2024
Same author

Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs.

ESMO open·2023
Same author

Corrigendum to "Validation and clinical application of a multiplex high performance liquid chromatography - Tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections" [J. Chromatogr. B 1157 (2020) 122160].

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2022
Same author

A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2022

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Patient Management

Context:

  • Multiple diseases present complex therapeutic challenges.
  • Limited clinical data exists for treating patients with comorbid conditions.
  • Practitioners face difficulties in prescribing or withholding medications.

Purpose:

  • To outline a rational prescribing framework for patients with multiple diseases.
  • To guide therapeutic decisions in the absence of extensive evidence.
  • To promote a patient-oriented, drug-sparing approach.

Summary:

  • Advocates for a patient-centered strategy over a disease-specific one.
  • Emphasizes rational prescribing principles: clear objectives, prioritization by severity, efficacy, safety, individualization, monitoring, and patient involvement.
  • Suggests a drug-sparing approach to mitigate risks associated with polypharmacy.

Impact:

  • Aims to improve therapeutic outcomes for patients with multiple comorbidities.
  • Provides a practical framework for clinicians managing complex cases.
  • Encourages shared decision-making and patient-centered care in polypharmacy.

Related Experiment Videos